LLY Shares Outstanding
Total shares outstanding each quarter, showing dilution from issuance or reduction from buybacks.
Shares Outstanding
Latest: 941M (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | 904M |
| 2024Q2 | 904M |
| 2024Q3 | 905M |
| 2024Q4 | 949M |
| 2025Q1 | 901M |
| 2025Q2 | 900M |
| 2025Q3 | 899M |
| 2025Q4 | 945M |
| 2026Q1 | 896M |
| 2026Q2 | 941M |
* In some reporting periods, diluted weighted-average shares are used instead of period-end shares outstanding. Please verify individual figures against the company's SEC filings.
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Shares Outstanding
Shares Outstanding
Shares Outstanding
Latest Shares Outstanding: 941M (2026Q2); +4.6% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, Shares Outstanding ranged from 896M in 2026Q1 to 949M in 2024Q4.